UBIO
ProShares UltraPro Nasdaq Biotechnology

Up$33.61
+$1.40
(+4.35%)
As of 9:58:07 AM EDT | 10/16/18  |  Market Open

UBIO Trading Data

Open

$33.38

Low Price

$32.95

High Price

$33.61

Previous Last Price

$32.21

Bid Size

$33.7 X 800

Ask Size

$33.78 X 100

UBIO Portfolio Data

AUM

$28,216,700

Shares

850

PE Ratio

16.86

Price / Book Ratio

4.16

Expense Ratio

0.95

Net Asset Value

$33.20

Volume

Volume

3,649

Avg. Volume (YDT)

68,570

Dollar Volume

$66,476

Weekly Avg. Volume

39,053

Monthly Avg. Volume

31,788

Quarterly Avg. Volume

29,767

UBIO Fund Description

ProShares UltraPro Nasdaq Biotechnology seeks daily investment results, before fees and expenses, that correspond to three times (3x) the daily performance of the NASDAQ Biotechnology Index.

UBIO Chart

UBIO Summary

Fund Family

ProShares

Tracks This Index

ProShares UltraPro Nasdaq Biotechnology

Inception Date

2015-06-22

Asset Class

Portfolio-Multi Asset

Asset Class Size

Biotech

UBIO Classification

Region (General)

North America

Region (Specific)

US

Sector

Health Care

Equity Index

Leveraged Family

UBIO Holdings

Top 10 Holdings

ProShares UltraPro Nasdaq Biotechnology (UBIO)
0%
NASDAQ Biotechnology Index SWAP UBS AG
0%
NASDAQ Biotechnology Index SWAP Bank of America NA
0%
NASDAQ Biotechnology Index SWAP Societe Generale
0%
NASDAQ Biotechnology Index SWAP Goldman Sachs International
0%
GILEAD SCIENCES INC (GILD)
0%
AMGEN INC (AMGN)
0%
BIOGEN IDEC INC (BIIB)
0%
CELGENE CORP (CELG)
0%
ILLUMINA INC (ILMN)
0%

Total UBIO Holdings

Total Holdings: 198

ProShares UltraPro Nasdaq Biotechnology (UBIO)
0%
NASDAQ Biotechnology Index SWAP UBS AG
0%
NASDAQ Biotechnology Index SWAP Bank of America NA
0%
NASDAQ Biotechnology Index SWAP Societe Generale
0%
NASDAQ Biotechnology Index SWAP Goldman Sachs International
0%
GILEAD SCIENCES INC (GILD)
0%
AMGEN INC (AMGN)
0%
BIOGEN IDEC INC (BIIB)
0%
CELGENE CORP (CELG)
0%
ILLUMINA INC (ILMN)
0%
REGENERON PHARMACEUTICALS INC (REGN)
0%
VERTEX PHARMACEUTICALS INC (VRTX)
0%
ALEXION PHARMACEUTICALS INC (ALXN)
0%
MYLAN INC (MYL)
0%
BIOMARIN PHARMACEUTICAL INC (BMRN)
0%
INCYTE CORP (INCY)
0%
SHIRE PLC (SHPG)
0%
SEATTLE GENETICS INC (SGEN)
0%
JAZZ PHARMACEUTICALS PLC (JAZZ)
0%
ALNYLAM PHARMACEUTICALS INC (ALNY)
0%
NEUROCRINE BIOSCIENCES INC (NBIX)
0%
SAREPTA THERAPEUTICS INC (SRPT)
0%
NEKTAR THERAPEUTICS (NKTR)
0%
BLUEBIRD BIO INC (BLUE)
0%
SAGE THERAPEUTICS INC (SAGE)
0%
EXELIXIS INC (EXEL)
0%
ALKERMES PLC (ALKS)
0%
PRA HEALTH SCIENCES INC (PRAH)
0%
BEIGENE LTD (BGNE)
0%
BIO-TECHNE CORP (TECH)
0%
IONIS PHARMACEUTICALS INC (IONS)
0%
FIBROGEN INC (FGEN)
0%
LOXO ONCOLOGY INC (LOXO)
0%
FOUNDATION MEDICINE INC (FMI)
0%
UNITED THERAPEUTICS CORP (UTHR)
0%
AGIOS PHARMACEUTICALS INC (AGIO)
0%
SYNEOS HEALTH INC (SYNH)
0%
LIGAND PHARMACEUTICALS INC (LGND)
0%
IMMUNOMEDICS INC (IMMU)
0%
ULTRAGENYX PHARMACEUTICAL INC (RARE)
0%
GW PHARMACEUTICALS PLC (GWPH)
0%
ARRAY BIOPHARMA INC (ARRY)
0%
CHINA BIOLOGIC PRODUCTS HOLD (CBPO)
0%
GRIFOLS SA (GRFS)
0%
SUPERNUS PHARMACEUTICALS INC (SUPN)
0%
SPARK THERAPEUTICS INC (ONCE)
0%
AMICUS THERAPEUTICS INC (FOLD)
0%
NOVOCURE LTD (NVCR)
0%
BLUEPRINT MEDICINES CORP (BPMC)
0%
CRISPR THERAPEUTICS AG (CRSP)
0%
HORIZON PHARMA PLC (HZNP)
0%
MEDICINES CO (MDCO)
0%
AERIE PHARMACEUTICALS INC (AERI)
0%
IRONWOOD PHARMACEUTICALS INC (IRWD)
0%
OPKO HEALTH INC (OPK)
0%
MYRIAD GENETICS INC (MYGN)
0%
ASCENDIS PHARMA A/S - ADR (ASND)
0%
PORTOLA PHARMACEUTICALS INC (PTLA)
0%
INTERCEPT PHARMACEUTICALS INC (ICPT)
0%
TESARO INC (TSRO)
0%
HALOZYME THERAPEUTICS INC (HALO)
0%
CLOVIS ONCOLOGY INC (CLVS)
0%
GLOBAL BLOOD THERAPEUTICS INC (GBT)
0%
REGENXBIO INC (RGNX)
0%
PUMA BIOTECHNOLOGY INC (PBYI)
0%
ENANTA PHARMACEUTICALS INC (ENTA)
0%
ACCELERON PHARMA INC (XLRN)
0%
SPECTRUM PHARMACEUTICALS INC (SPPI)
0%
ARENA PHARMACEUTICALS INC (ARNA)
0%
ENDO INTL PLC (ENDP)
0%
XENCOR INC (XNCR)
0%
REPLIGEN CORP (RGEN)
0%
AKCEA THERAPEUTICS INC (AKCA)
0%
MYOKARDIA INC (MYOK)
0%
ACADIA PHARMACEUTICALS INC (ACAD)
0%
INSMED INC (INSM)
0%
GENOMIC HEALTH INC (GHDX)
0%
EDITAS MEDICINE INC (EDIT)
0%
ANAPTYSBIO INC (ANAB)
0%
ATARA BIOTHERAPEUTICS INC (ATRA)
0%
MOMENTA PHARMACEUTICALS INC (MNTA)
0%
PTC THERAPEUTICS INC (PTCT)
0%
AIMMUNE THERAPEUTICS INC (AIMT)
0%
ZOGENIX INC (ZGNX)
0%
MEDPACE HOLDINGS INC (MEDP)
0%
SANGAMO BIOSCIENCES INC (SGMO)
0%
G1 THERAPEUTICS INC (GTHX)
0%
AUDENTES THERAPEUTICS INC (BOLD)
0%
INNOVIVA INC (INVA)
0%
UNIQURE NV (QURE)
0%
THERAPEUTICSMD INC (TXMD)
0%
ACORDA THERAPEUTICS INC (ACOR)
0%
RADIUS HEALTH INC (RDUS)
0%
LUMINEX CORP (LMNX)
0%
PACIRA PHARMACEUTICALS INC (PCRX)
0%
IMMUNOGEN INC (IMGN)
0%
LEXICON PHARMACEUTICALS INC (LXRX)
0%
THERAVANCE BIOPHARMA INC (TBPH)
0%
ARROWHEAD PHARMACEUTICALS INC (ARWR)
0%
ATHENEX INC (ATNX)
0%
INTELLIA THERAPEUTICS INC (NTLA)
0%
IOVANCE BIOTHERAPEUTICS INC (IOVA)
0%
EAGLE PHARMACEUTICALS INC (EGRX)
0%
RETROPHIN INC (RTRX)
0%
ALDER BIOPHARMACEUTICALS INC (ALDR)
0%
ESPERION THERAPEUTICS INC (ESPR)
0%
KARYOPHARM THERAPEUTICS INC (KPTI)
0%
REVANCE THERAPEUTICS INC (RVNC)
0%
VANDA PHARMACEUTICALS INC (VNDA)
0%
FLEXION THERAPEUTICS INC (FLXN)
0%
INTRA-CELLULAR THERAPIES INC (ITCI)
0%
ENDOCYTE INC (ECYT)
0%
EPIZYME INC (EPZM)
0%
COHERUS BIOSCIENCES INC (CHRS)
0%
GALAPAGOS NV-SPON ADR (GLPG)
0%
AMARIN CORP PLC (AMRN)
0%
CYTOMX THERAPEUTICS INC (CTMX)
0%
OMEROS CORP (OMER)
0%
MACROGENICS INC (MGNX)
0%
CERUS CORP (CERS)
0%
DOVA PHARMACEUTICALS INC (DOVA)
0%
ANI PHARMACEUTICALS INC (ANIP)
0%
COLLEGIUM PHARMACEUTICAL INC (COLL)
0%
ADAPTIMMUNE THERAPEUTICS-ADR (ADAP)
0%
AMPHASTAR PHARMACEUTICALS INC (AMPH)
0%
REATA PHARMACEUTICALS INC (RETA)
0%
ADAMAS PHARMACEUTICALS INC (ADMS)
0%
GLYCOMIMETICS INC (GLYC)
0%
AMAG PHARMACEUTICALS INC (AMAG)
0%
CHEMOCENTRYX INC (CCXI)
0%
VOYAGER THERAPEUTICS INC (VYGR)
0%
CARA THERAPEUTICS INC (CARA)
0%
ACLARIS THERAPEUTICS INC (ACRS)
0%
KURA ONCOLOGY INC (KURA)
0%
GERON CORP (GERN)
0%
PROGENICS PHARMACEUTICALS INC (PGNX)
0%
CALYXT INC (CLXT)
0%
PROTHENA CORP PLC (PRTA)
0%
AKEBIA THERAPEUTICS INC (AKBA)
0%
BIOCRYST PHARMACEUTICALS INC (BCRX)
0%
FIVE PRIME THERAPEUTICS INC (FPRX)
0%
ADURO BIOTECH INC (ADRO)
0%
INSYS THERAPEUTICS INC (INSY)
0%
DBV TECHNOLOGIES SA (DBVT)
0%
NOVAVAX INC (NVAX)
0%
AURINIA PHARMACEUTICALS INC (AUPH)
0%
PACIFIC BIOSCIENCES OF CALIFORNIA INC (PACB)
0%
RIGEL PHARMACEUTICALS INC (RIGL)
0%
CYTOKINETICS INC (CYTK)
0%
PETIQ INC (PETQ)
0%
SYNERGY PHARMACEUTICALS INC (SGYP)
0%
DEPOMED INC (DEPO)
0%
MERSANA THERAPEUTICS INC (MRSN)
0%
ARBUTUS BIOPHARMA CORP (ABUS)
0%
CONCERT PHARMACEUTICALS INC (CNCE)
0%
ACHILLION PHARMACEUTICALS INC (ACHN)
0%
ACHAOGEN INC (AKAO)
0%
DERMIRA INC (DERM)
0%
NANTHEALTH INC (NH)
0%
INOVIO PHARMACEUTICALS INC (INO)
0%
PDL BIOPHARMA INC (PDLI)
0%
NANOSTRING TECHNOLOGIES INC (NSTG)
0%
SERES THERAPEUTICS INC (MCRB)
0%
SAVARA INC (SVRA)
0%
KALA PHARMACEUTICALS INC (KALA)
0%
PARATEK PHARMACEUTICALS INC (PRTK)
0%
RA PHARMACEUTICALS INC (RARX)
0%
CORVUS PHARMACEUTICALS INC (CRVS)
0%
VERACYTE INC (VCYT)
0%
MINERVA NEUROSCIENCES INC (NERV)
0%
BELLICUM PHARMACEUTICALS INC (BLCM)
0%
SIENNA BIOPHARMACEUTICALS IN (SNNA)
0%
CELLECTIS - ADR (CLLS)
0%
VITAL THERAPIES INC (VTL)
0%
CORIUM INTERNATIONAL INC (CORI)
0%
CORBUS PHARMACEUTICALS HOLDI (CRBP)
0%
MARINUS PHARMACEUTICALS INC (MRNS)
0%
STRONGBRIDGE BIOPHARMA PLC (SBBP)
0%
MANNKIND CORP (MNKD)
0%
AVADEL PHARMACEUTICALS PLC (AVDL)
0%
JOUNCE THERAPEUTICS INC (JNCE)
0%
AXOVANT SCIENCES LTD (AXON)
0%
NANTKWEST INC (NK)
0%
CHIMERIX INC (CMRX)
0%
ARDELYX INC (ARDX)
0%
FOAMIX PHARMACEUTICALS LTD (FOMX)
0%
ARATANA THERAPEUTICS INC (PETX)
0%
TOCAGEN INC (TOCA)
0%
TELIGENT INC (TLGT)
0%
TETRAPHASE PHARMACEUTICALS INC (TTPH)
0%
NEOS THERAPEUTICS INC (NEOS)
0%
CALITHERA BIOSCIENCES INC (CALA)
0%
NEWLINK GENETICS CORP (NLNK)
0%
SYNDAX PHARMACEUTICALS INC (SNDX)
0%
NABRIVA THERAPEUTICS PLC (NBRV)
0%
CELLDEX THERAPEUTICS INC (CLDX)
0%
CURIS INC (CRIS)
0%
Net Other Assets / Cash
0%

UBIO Technicals

Alpha

-59.22

Beta

4.63

Leverage

Triple-Long

Standard Deviation

4.55

UBIO Dividends

Dividend Date

Latest Dividend

Annual Dividend

0

Annual Dividend Rate

0

Annual Dividend Yield

1.0E-5

UBIO Performance

YTD Return

-1.43%

1 Year Return

-16.52%

3 Year Return

-33.79%

5 Year Return

0%

10 Year Return

-63.87%

UBIO Related Articles

Biotech ETFs Pop on Celgene, Juno Deal

Biotech ETFs Pop on Celgene, Juno Deal

Biotechnology sector-related ETFs surged Monday after Celgene (NasdaqGS: CELG) said it will acquire Juno Therapeutics (NasdaqGS: JUNO) to expand its cancer treatment profile. Among the best performing biotech-related ETFs, the…

Evaluating the Biotech ETF Rally

Evaluating the Biotech ETF Rally

The SPDR S&P Biotech ETF (NYSEArca: XBI), one of the largest biotech ETFs, is getting in on the sector’s resurgence. XBI, an equal-weight fund, is up more than 40% year-to-date…

Biotech, Pharma ETFs Leave Pricing Drama Behind

Biotech, Pharma ETFs Leave Pricing Drama Behind

Biotechnology and pharmaceutical ETFs have rallied in recent weeks as drug pricing concerns wane and investors look to the opportunity of this market segment. The iShares Nasdaq Biotechnology ETF (NASDAQGM: IBB),…

Biotech ETF Investing is Hot, Can Get Hotter

Biotech ETF Investing is Hot, Can Get Hotter

Up more than 42% year-to-date, the SPDR S&P Biotech ETF (NYSEArca: XBI), one of the largest biotechnology ETFs, is one of this year’s best-performing non-leveraged ETFs. That does not mean…

September Could be Kind to Biotechnology ETFs

September Could be Kind to Biotechnology ETFs

The iShares Nasdaq Biotechnology ETF (NASDAQGM: IBB), the largest biotechnology exchange traded fund by assets, is up nearly 18% and the behemoth biotech fund could add to those gains in September.…

Biotech ETFs Prescribe Investing Momentum

Biotech ETFs Prescribe Investing Momentum

Biotechnology exchange traded funds are extending what is an impressive 2017 resurgence after the group faltered last year. iShares Nasdaq Biotechnology ETF (NASDAQGM:IBB), the largest biotechnology exchange traded fund by…